Aster Capital Management (Difc) LTD Harmony Biosciences Holdings, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 557 shares of HRMY stock, worth $21,711. This represents 0.01% of its overall portfolio holdings.
Number of Shares
557Holding current value
$21,711% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
254Shares Held
46.6MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$258 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$227 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$185 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$88.9 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$61.6 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.31B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...